Celcuity Inc. (CELC)Healthcare | Biotechnology | Minneapolis, United States | NasdaqCM
103.79 USD
-3.79
(-3.523%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 105.43 +1.64 (1.582%) ⇧ (July 13, 2026, 6:33 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:16 a.m. EDT
Celcuity presents a classic high-risk biotech dilemma where analyst optimism clashes with financial reality. While the stock has rallied sharply over the last two weeks and carries a 'Strong Buy' consensus with a target price nearly 50% higher, the underlying fundamentals remain precarious. The company is burning cash, reporting negative earnings, and trades at a premium valuation that defies traditional metrics. The options market reflects this uncertainty, with implied volatility remaining elevated and speculators positioning on both sides of the trade. For investors seeking capital preservation, the lack of dividends and negative free cash flow make this a poor fit. However, those willing to tolerate extreme volatility for potential clinical trial breakthroughs may find the current price attractive relative to the upside targets, though the path remains fraught with binary risks. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.222204 |
| AutoETS | 0.225019 |
| AutoTheta | 0.242991 |
| AutoARIMA | 0.277075 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 40.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.083 |
| Excess Kurtosis | -1.63 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 604.28 |
| Market Cap | 5,061,453,312 |
| Forward P/E | 140.26 |
| Beta | 0.16 |
| Website | https://www.celcuity.com |
As of July 11, 2026, 6:16 a.m. EDT: Implied volatility remains elevated across all expirations, signaling heightened uncertainty. Call buyers are clustering around the $120 to $130 strikes, while put writers are heavily positioned at the $95 to $100 levels. This creates a dense wall of options interest near the current price, suggesting traders are anticipating a binary event or significant price swing rather than a steady trend. The presence of volume spikes at distant strikes indicates speculation on extreme outcomes.
| Attribute | Value |
|---|---|
| 52 Week Change | 6.824 |
| Address1 | 2,800 Campus Drive |
| Address2 | Suite 140 |
| All Time High | 151.02 |
| All Time Low | 4.03 |
| Ask | 130.09 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 1,260,330 |
| Average Daily Volume3 Month | 1,375,603 |
| Average Volume | 1,375,603 |
| Average Volume10Days | 1,260,330 |
| Beta | 0.164 |
| Bid | 78.04 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | 1.107 |
| City | Minneapolis |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 103.79 |
| Current Ratio | 12.313 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 108.69 |
| Day Low | 100.625 |
| Debt To Equity | 604.28 |
| Display Name | Celcuity |
| Earnings Call Timestamp End | 1,778,790,600 |
| Earnings Call Timestamp Start | 1,778,790,600 |
| Earnings Timestamp | 1,778,788,800 |
| Earnings Timestamp End | 1,786,651,200 |
| Earnings Timestamp Start | 1,786,651,200 |
| Ebitda | -186,388,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -26.814 |
| Enterprise Value | 4,997,830,144 |
| Eps Current Year | -3.53 |
| Eps Forward | 0.74 |
| Eps Trailing Twelve Months | -3.91 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 112.907 |
| Fifty Day Average Change | -9.116997 |
| Fifty Day Average Change Percent | -0.08074784 |
| Fifty Two Week Change Percent | 682.39996 |
| Fifty Two Week High | 151.02 |
| Fifty Two Week High Change | -47.230003 |
| Fifty Two Week High Change Percent | -0.31274006 |
| Fifty Two Week Low | 13.365 |
| Fifty Two Week Low Change | 90.425 |
| Fifty Two Week Low Change Percent | 6.7658067 |
| Fifty Two Week Range | 13.365 - 151.02 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,505,914,200,000 |
| Float Shares | 26,813,656 |
| Forward Eps | 0.74 |
| Forward P E | 140.25676 |
| Free Cashflow | -110,841,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 155 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10027 |
| Held Percent Institutions | 1.01769 |
| Implied Shares Outstanding | 48,766,288 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota. |
| Long Name | Celcuity Inc. |
| Market | us_market |
| Market Cap | 5,061,453,312 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_254573983 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -192,886,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,246,277,263 |
| Number Of Analyst Opinions | 11 |
| Open | 106.7 |
| Operating Cashflow | -172,492,000 |
| Operating Margins | 0.0 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | (763) 392-0123 |
| Post Market Change | 1.6419983 |
| Post Market Change Percent | 1.582039 |
| Post Market Price | 105.432 |
| Post Market Time | 1,783,982,035 |
| Previous Close | 107.58 |
| Price Eps Current Year | -29.402267 |
| Price Hint | 2 |
| Price To Book | 93.757904 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.655 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.16667 |
| Region | US |
| Regular Market Change | -3.79 |
| Regular Market Change Percent | -3.52296 |
| Regular Market Day High | 108.69 |
| Regular Market Day Low | 100.625 |
| Regular Market Day Range | 100.625 - 108.69 |
| Regular Market Open | 106.7 |
| Regular Market Previous Close | 107.58 |
| Regular Market Price | 103.79 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 1,242,983 |
| Return On Assets | -0.37118 |
| Return On Equity | -2.75172 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 48,766,288 |
| Shares Percent Shares Out | 0.22489999 |
| Shares Short | 10,969,220 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 9,601,855 |
| Short Name | Celcuity Inc. |
| Short Percent Of Float | 0.338 |
| Short Ratio | 5.67 |
| Source Interval | 15 |
| State | MN |
| Symbol | CELC |
| Target High Price | 175.0 |
| Target Low Price | 145.0 |
| Target Mean Price | 160.81818 |
| Target Median Price | 160.0 |
| Total Cash | 387,064,000 |
| Total Cash Per Share | 7.937 |
| Total Debt | 323,440,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.91 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 100.7191 |
| Two Hundred Day Average Change | 3.0709 |
| Two Hundred Day Average Change Percent | 0.030489748 |
| Type Disp | Equity |
| Volume | 1,242,983 |
| Website | https://www.celcuity.com |
| Zip | 55,441 |